Pricing Log in Create free account
Friday 6 November 2026 Export BAX’s income statement to Excel — free account

Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.

Revenue
+4.97%
EPS
+731.9%
Free cash flow
+255.6%
Total debt
−9.48%

Quarter to September 2026, against a year earlier

25.57 0.93 −3.51%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
21.3×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Baxter International Inc. (BAX) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Baxter International Inc. (BAX) trades at a EV/EBITDA of 13.2×. Over the past ten years it has ranged from 10.2× (March 2015) to 45.0× (December 2023); the current reading is higher than 9% of that period. That is below the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 12.0× (32.27%)
FY2024 17.7× (1.59%)
FY2023 17.9× (38.95%)
FY2022 29.4× 12.72%
FY2021 26.1× 47.87%
FY2020 17.6× 2.52%
FY2019 17.2× 10.07%
FY2018 15.6× (12.98%)
FY2017 18.0× 14.41%
FY2016 15.7× (5.28%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 12.6× 0.05%
Jun 2026 12.6× 13.25%
Mar 2026 11.1× (6.89%)
Dec 2025 12.0× (11.18%)
43 more quarters

Against its own ten years

Low 10.2× High 45.0×
Ten-year median 17.7×
Current reading's percentile 9

EV/EBITDA against peers

Company EV/EBITDA
SOLV Solventum Corporation compare 7.6×
ALGN Align Technology, Inc. compare 12.6×
BAX Baxter International Inc. 13.2×
ATR AptarGroup, Inc. compare 13.2×
BLCO Bausch + Lomb Corporation compare 14.6×
AVTR Avantor, Inc. compare 14.7×
COO The Cooper Companies, Inc. compare 15.8×
WST West Pharmaceutical Services, Inc. compare 28.4×
RGEN Repligen Corporation compare 60.1×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BAX